IL-22 Participates in an Innate Anti-HIV-1 Host-Resistance Network through Acute-Phase Protein Induction1
暂无分享,去创建一个
D. Missé | J. Gonzalez | M. Clerici | S. Lo Caputo | F. Mazzotta | F. Veas | H. Yssel | D. Trabattoni | J. Pène | Christelle Oblet
[1] C. Chougnet,et al. Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals. , 2006, Clinical immunology.
[2] S. Ziegler,et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. , 2006, The Journal of clinical investigation.
[3] R Tibshirani,et al. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification , 2006, Oncogene.
[4] Roland Lang,et al. Tuning of macrophage responses by Stat3-inducing cytokines: molecular mechanisms and consequences in infection. , 2005, Immunobiology.
[5] Mario Clerici,et al. Genotypes at chromosome 22q12-13 are associated with HIV-1-exposed but uninfected status in Italians , 2005, AIDS.
[6] Xavier Anglaret,et al. Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting , 2005, Journal of Clinical Microbiology.
[7] M. Clerici,et al. Distinct patterns of HIV-specific memory T lymphocytes in HIV-exposed uninfected individuals and in HIV-infected patients , 2005, AIDS.
[8] K. Asadullah,et al. IL-22 increases the innate immunity of tissues. , 2004, Immunity.
[9] P. Kaleebu,et al. Distinct patterns of peripheral HIV-1-specific interferon- gamma responses in exposed HIV-1-seronegative individuals. , 2004, The Journal of infectious diseases.
[10] R. de Waal Malefyt,et al. Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. , 2004, International immunopharmacology.
[11] M. Clerici,et al. Human &agr; Defensin in HIV-Exposed But Uninfected Individuals , 2004 .
[12] D. McDermott,et al. Role for CCR5Δ32 Protein in Resistance to R5, R5X4, and X4 Human Immunodeficiency Virus Type 1 in Primary CD4+ Cells , 2004, Journal of Virology.
[13] C. Thorn,et al. Regulation of the Human Acute Phase Serum Amyloid A Genes by Tumour Necrosis Factor‐α, Interleukin‐6 and Glucocorticoids in Hepatic and Epithelial Cell Lines , 2004, Scandinavian journal of immunology.
[14] D. Scott‐Algara,et al. Cutting Edge: Increased NK Cell Activity in HIV-1-Exposed but Uninfected Vietnamese Intravascular Drug Users 1 , 2003, The Journal of Immunology.
[15] M. Lederman,et al. Human epithelial β-defensins 2 and 3 inhibit HIV-1 replication , 2003 .
[16] H. Jaspan,et al. Expression of granzyme B mRNA is altered in human immunodeficiency virus infected patients. , 2003, Experimental and molecular pathology.
[17] J. Lieberman,et al. HIV-1 Antiviral Activity of Recombinant Natural Killer Cell Enhancing Factors, NKEF-A and NKEF-B, Members of the Peroxiredoxin Family* , 2003, The Journal of Biological Chemistry.
[18] K. Asadullah,et al. Cutting Edge: Immune Cells as Sources and Targets of the IL-10 Family Members? , 2002, The Journal of Immunology.
[19] Ji Huang,et al. [Serial analysis of gene expression]. , 2002, Yi chuan = Hereditas.
[20] W. Gong,et al. Desensitization of chemokine receptor CCR5 in dendritic cells at the early stage of differentiation by activation of formyl peptide receptors. , 2001, Clinical immunology.
[21] Ji Ming Wang,et al. Pleiotropic roles of formyl peptide receptors. , 2001, Cytokine & growth factor reviews.
[22] J. Renauld,et al. IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes , 2000, Genes and Immunity.
[23] J. Renauld,et al. Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[24] D. Missé,et al. A CD4-independent interaction of human immunodeficiency virus-1 gp120 with CXCR4 induces their cointernalization, cell signaling, and T-cell chemotaxis. , 1999, Blood.
[25] M. Oppermann,et al. Differential Effects of CC Chemokines on CC Chemokine Receptor 5 (CCR5) Phosphorylation and Identification of Phosphorylation Sites on the CCR5 Carboxyl Terminus* , 1999, The Journal of Biological Chemistry.
[26] J. Skurnick,et al. Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[27] M. Clerici,et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals , 1997, Nature Medicine.
[28] J. Claverie,et al. The significance of digital gene expression profiles. , 1997, Genome research.
[29] N. Nagelkerke,et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya , 1996, The Lancet.
[30] Marc Parmentier,et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.
[31] Steven M. Wolinsky,et al. Relative resistance to HIV–1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high–risk sexual exposures , 1996, Nature Medicine.
[32] S. Rowland-Jones,et al. Immune responses in HIV-exposed seronegatives: have they repelled the virus? , 1995, Current opinion in immunology.
[33] R. Coffman,et al. Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[34] J. Levy,et al. Suppression of HIV replication by CD8+ cell clones derived from HIV-infected and uninfected individuals. , 1994, Cellular immunology.
[35] J. Liepnieks,et al. Fibril formation from recombinant human serum amyloid A. , 1994, Biochimica et biophysica acta.
[36] P. Sharp,et al. Evolution of the serum amyloid A (SAA) protein superfamily. , 1994, Genomics.
[37] J. Ghrayeb,et al. T-cell response towards HIV in infected individuals with and without zidovudine therapy, and in HIV-exposed sexual partners. , 1989, AIDS.
[38] W. V. van Blitterswijk,et al. Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. , 1984, Journal of immunological methods.
[39] W. Heath,et al. SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation. , 2006, Tissue antigens.
[40] Miller,et al. of Tissues , 2003 .
[41] S. Kaufmann,et al. Immunology of infection , 1999 .
[42] A. Scheffold,et al. 1 Phenotyping and Separation of Leukocyte Populations Based on Affinity Labelling , 1998 .
[43] M. Clerici,et al. Protective immunity against HIV infection: has nature done the experiment for us? , 1996, Immunology today.